Eating DisordersNCT07350720
Inpatient Care of Patients With Difficult to Treat Anorexia Nervosa - Factors Affecting Treatment Outcome.
An observational study of Eating Disorders and Anorexia Nervosa, run by Region Skane.
Trial summary
The overall aim of the project is to investigate factors that may influence treatment outcomes in people with difficult-to-treat anorexia nervosa who are enrolled in inpatient care at the Region Skåne Eating Disorders Centre in Lund. Read more about this study
- Who is it for?
- Ages 18 to 64 years
- Conditions the study is for
- Eating Disorders, Anorexia Nervosa
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- Sep 2026to Dec 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- No healthy volunteers
- Adult
Study population: Individuals with anorexia nervosa admitted to inpatient care at Region Skåne Eating Disorders Center, a specialized psychiatric care unit for treatment of eating disorders.
Who may be able to join
- Anorexia Nervosa diagnosis (ICD F50.0)
- Admitted to inpatient care at department 5 at Region Skåne Eating Disorders Center
Who cannot join
- Confidential identity
- Inability to read or write in Swedish or English
- Condition or treatment that, according to the study team, makes participation in the study inappropriate
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Inpatient Care of Patients With Difficult to Treat Eating Disorders - What Affects Treatment Outcome?
The overall aim of the project is to investigate factors that may influence treatment outcomes in people with difficult-to-treat anorexia nervosa who are enrolled in inpatient care at the Region Skåne Eating Disorders Centre in Lund. Treatment expectations, sense of autonomy, and patient participation, will be investigated, as well as caregivers' attitudes towards, and experiences of working with, autonomy and patient participation in the inpatient setting. The research project is expected to contribute to increased knowledge about the treatment of difficult-to-treat anorexia nervosa, and what part patient participation and autonomy may play when treating severe eating disorders. The overall objectives of the research program are:
- To contribute to increased knowledge about factors that influence the treatment of people with difficult-to-treat anorexia nervosa
- To highlight the role of autonomy and patient participation in inpatient care of severe eating disorders
- To use the research results for clinical improvement work at Region Skåne Eating Disorders Center
- Conditions
- Eating Disorders, Anorexia Nervosa
- Medical subject headings
- Feeding and Eating Disorders, Anorexia Nervosa
What is being measured
The primary outcome is the main question the study is designed to answer.
Body Mass Index (BMI)
BMI is calculated using weight and height: weight (kg) / (height (m) x height (m))
Measured: BMI will be calulated on a weekly basis throughout the inpatient treatment period, and baseline measures until end of treatment/discharge from inpatient unit at approximately 12 weeks will be used for analysis.
Secondary outcomes (1)
Treatment satisfaction
Satisfaction with treatment will be measured using the Client Satisfaction Questionnaire (CSQ-8), which contains 8 items. Total scores range from 8 to 32, with higher scores indicating greater satisfaction.
Measured: CSQ-8 is collected at the end of treatment/at discharge from inpatient care at approximately 12 weeks as well at 1 year follow-up after discharge, in order to evaluate the treatment given.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jan 2026
- Study startSep 2026 (estimated)
- Primary completionDec 2028 (estimated)
- Study completionDec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Eating DisordersStudies of the same condition, open and under way.
- More trials run by Region SkaneThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Region Skane
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Emelia Mellergård, PhD, Principal investigator, Region Skåne VO Vuxenpsykiatri Lund
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07350720
- Sponsor's protocol ID
- 2024-07313-01
- Status last verified
- Jun 2026
- First submitted
- 19 Dec 2025
- Last updated
- 16 Jun 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Inpatient Care of Patients With Difficult to Treat Eating Disorders - What Affects Treatment Outcome?
- ClinicalTrials.gov ID
- NCT07350720
- Acronym / sponsor ID
- 2024-07313-01
- Conditions
- Eating Disorders, Anorexia Nervosa
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Region SkaneUniversity, hospital or other
- Study start
- Sep 2026 (estimated)
- Primary completion
- Dec 2028 (estimated)
- Study completion
- Dec 2029 (estimated)
- First posted
- 20 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The overall aim of the project is to investigate factors that may influence treatment outcomes in people with difficult-to-treat anorexia nervosa who are enrolled in inpatient care at the Region Skåne Eating Disorders Centre in Lund. Treatment expectations, sense of autonomy, and patient participation, will be investigated, as well as caregivers' attitudes towards, and experiences of working with, autonomy and patient participation in the inpatient setting. The research project is expected to contribute to increased knowledge about the treatment of difficult-to-treat anorexia nervosa, and what part patient participation and autonomy may play when treating severe eating disorders. The overall objectives of the research program are:
- To contribute to increased knowledge about factors that influence the treatment of people with difficult-to-treat anorexia nervosa
- To highlight the role of autonomy and patient participation in inpatient care of severe eating disorders
- To use the research results for clinical improvement work at Region Skåne Eating Disorders Center
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Individuals with anorexia nervosa admitted to inpatient care at Region Skåne Eating Disorders Center, a specialized psychiatric care unit for treatment of eating disorders.
Key inclusion criteria (2 listed)
- Anorexia Nervosa diagnosis (ICD F50.0)
- Admitted to inpatient care at department 5 at Region Skåne Eating Disorders Center
Key exclusion criteria (3 listed)
- Confidential identity
- Inability to read or write in Swedish or English
- Condition or treatment that, according to the study team, makes participation in the study inappropriate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Body Mass Index (BMI)
Time frame: BMI will be calulated on a weekly basis throughout the inpatient treatment period, and baseline measures until end of treatment/discharge from inpatient unit at approximately 12 weeks will be used for analysis.
BMI is calculated using weight and height: weight (kg) / (height (m) x height (m))
1 secondary outcome
Treatment satisfaction
Time frame: CSQ-8 is collected at the end of treatment/at discharge from inpatient care at approximately 12 weeks as well at 1 year follow-up after discharge, in order to evaluate the treatment given.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2026.
- Individual participant dataSharing planned: No
Related trials for Eating Disorders
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
Enrolling by invitationPhase 3
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
Binge-Eating Disorder
Recruiting
An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
Excessive Gestational Weight Gain, Pregnancy
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Emelia Mellergård, PhD principal investigator
Region Skåne VO Vuxenpsykiatri Lund
Questions about this trial
What is this clinical trial studying?
An observational study of Eating Disorders and Anorexia Nervosa, run by Region Skane.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Emelia Mellergård, PhD (+46709407381, emelia.mellergard@skane.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Body Mass Index (BMI) (time frame: BMI will be calulated on a weekly basis throughout the inpatient treatment period, and baseline measures until end of treatment/discharge from inpatient unit at approximately 12 weeks will be used for analysis.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.